| 1 |
34605949 |
10.1007/s00277-021-04671-0 |
2022 |
Characterization of molecular genetics and clinicopathology in thymic MALT lymphoma. |
CARD11 |
| 2 |
34654055 |
10.1182/bloodadvances.2021006034 |
2022 |
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements. |
CARD11 |
| 3 |
34664256 |
10.1111/bjh.17894 |
2022 |
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNA. |
CARD11 |
| 4 |
34783281 |
10.1080/10428194.2021.1999444 |
2022 |
Targeting MALT1 for the treatment of diffuse large B-cell lymphoma. |
CARD11 |
| 5 |
34791836 |
10.1002/cam4.4422 |
2022 |
Identification of a genetic signature enriching for response to ibrutinib in relapsed/refractory follicular lymphoma in the DAWN phase 2 trial. |
CARD11 |
| 6 |
34837284 |
10.1111/cas.15224 |
2022 |
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma. |
CARD11 |
| 7 |
35038193 |
10.1111/his.14617 |
2022 |
Incidence, clinicopathological features and genetics of in-situ follicular neoplasia: a comprehensive screening study in a Japanese cohort. |
CARD11 |
| 8 |
35099607 |
10.1007/s00018-022-04154-z |
2022 |
A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells. |
CARD11 |
| 9 |
35158799 |
10.3390/cancers14030531 |
2022 |
CARD9 Forms an Alternative CBM Complex in Richter Syndrome. |
CARD11 |
| 10 |
35218741 |
10.1016/j.bcp.2022.114977 |
2022 |
Post-translational modification of MALT1 and its role in B cell- and T cell-related diseases. |
CARD11 |
| 11 |
35230873 |
10.1126/scisignal.abk3083 |
2022 |
Phosphorylation of serine-893 in CARD11 suppresses the formation and activity of the CARD11-BCL10-MALT1 complex in T and B cells. |
CARD11 |
| 12 |
35240014 |
10.4143/crt.2022.017 |
2022 |
Circulating Tumor DNA-Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas. |
CARD11 |
| 13 |
35255409 |
10.1016/j.jbior.2022.100890 |
2022 |
CARD11 signaling in regulatory T cell development and function. |
CARD11 |
| 14 |
35411950 |
10.1002/cbf.3702 |
2022 |
USP7 sustains an active epigenetic program via stabilizing MLL2 and WDR5 in diffuse large B-cell lymphoma. |
CARD11 |
| 15 |
35651609 |
10.3389/fimmu.2022.878989 |
2022 |
Hyper-IgE and Carcinoma in CADINS Disease. |
CARD11 |
| 16 |
35658124 |
10.1158/2159-8290.CD-21-1566 |
2022 |
BCL10 Mutations Define Distinct Dependencies Guiding Precision Therapy for DLBCL. |
CARD11 |
| 17 |
35734168 |
10.3389/fimmu.2022.922471 |
2022 |
m6A-Regulator Expression Signatures Identify a Subset of Follicular Lymphoma Harboring an Exhausted Tumor Microenvironment. |
CARD11 |
| 18 |
35885931 |
10.3390/genes13071144 |
2022 |
Targeting a Novel G-Quadruplex in the <i>CARD11</i> Oncogene Promoter with Naptho(2,1-b)furan-1-ethanol,2-nitro- Requires the Nitro Group. |
CARD11 |
| 19 |
35928872 |
10.3389/fonc.2022.932674 |
2022 |
Cell-Free DNA Sequencing of Intraocular Fluid as Liquid Biopsy in the Diagnosis of Vitreoretinal Lymphoma. |
CARD11 |
| 20 |
35954378 |
10.3390/cancers14153716 |
2022 |
Mutations Affecting Genes in the Proximal T-Cell Receptor Signaling Pathway in Peripheral T-Cell Lymphoma. |
CARD11 |
| 21 |
35981904 |
10.1016/j.jaci.2022.06.023 |
2022 |
The role of the CBM complex in allergic inflammation and disease. |
CARD11 |
| 22 |
36051079 |
10.1002/jha2.428 |
2022 |
Targetable alterations in primary extranodal diffuse large B-cell lymphoma. |
CARD11 |
| 23 |
32583848 |
10.1093/neuonc/noaa145 |
2021 |
Phase I/II study of tirabrutinib, a second-generation Bruton's tyrosine kinase inhibitor, in relapsed/refractory primary central nervous system lymphoma. |
CARD11 |
| 24 |
32790937 |
10.1111/febs.15522 |
2021 |
Defining the combinatorial space of PKC::CARD-CC signal transduction nodes. |
CARD11 |
| 25 |
33034903 |
10.1002/hon.2816 |
2021 |
B cell receptor signaling related to resistance to Helicobacter pylori eradication therapy in gastric diffuse large B cell lymphoma. |
CARD11 |
| 26 |
33098696 |
10.1111/ejh.13540 |
2021 |
RLTPR Q575E: A novel recurrent gain-of-function mutation in patients with adult T-cell leukemia/lymphoma. |
CARD11 |
| 27 |
33232972 |
10.1182/blood.2020005244 |
2021 |
Adaptive T-cell immunity controls senescence-prone MyD88- or CARD11-mutant B-cell lymphomas. |
CARD11 |
| 28 |
33263441 |
10.1080/17474086.2021.1856652 |
2021 |
Development of molecular intervention strategies for B-cell lymphoma. |
CARD11 |
| 29 |
33399078 |
10.1016/j.esmoop.2020.100012 |
2021 |
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence. |
CARD11 |
| 30 |
33426772 |
10.1111/cas.14806 |
2021 |
Genetic profile of adult T-cell leukemia/lymphoma in Okinawa: Association with prognosis, ethnicity, and HTLV-1 strains. |
CARD11 |
| 31 |
33479306 |
10.1038/s41598-020-80376-0 |
2021 |
Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma. |
CARD11 |
| 32 |
33542970 |
10.1200/PO.20.00360 |
2021 |
Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell Lymphoma. |
CARD11 |
| 33 |
33561953 |
10.3390/cancers13040650 |
2021 |
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies. |
CARD11 |
| 34 |
33581493 |
10.1016/j.ctarc.2021.100310 |
2021 |
Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients. |
CARD11 |
| 35 |
33872653 |
10.1016/j.jaci.2021.04.006 |
2021 |
Mechanistic understanding of the combined immunodeficiency in complete human CARD11 deficiency. |
CARD11 |
| 36 |
33918793 |
10.3390/cancers13081801 |
2021 |
Clinical Applications of Genomic Alterations in ATLL: Predictive Markers and Therapeutic Targets. |
CARD11 |
| 37 |
33951889 |
10.3324/haematol.2020.271957 |
2021 |
MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma. |
CARD11 |
| 38 |
34177947 |
10.3389/fimmu.2021.689472 |
2021 |
Resistance Mutations to BTK Inhibitors Originate From the NF-κB but Not From the PI3K-RAS-MAPK Arm of the B Cell Receptor Signaling Pathway. |
CARD11 |
| 39 |
34203889 |
10.3390/cancers13122993 |
2021 |
Genetic Characterization and Clinical Features of <i>Helicobacter pylori</i> Negative Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. |
CARD11 |
| 40 |
34223928 |
10.1007/s00109-021-02101-2 |
2021 |
CARMA1 is required for Notch1-induced NF-κB activation in SIL-TAL1-negative T cell acute lymphoblastic leukemia. |
CARD11 |
| 41 |
34236636 |
10.1007/978-1-0716-1669-7_8 |
2021 |
Methods to Study CARD11-BCL10-MALT1 Dependent Canonical NF-κB Activation in Jurkat T Cells. |
CARD11 |
| 42 |
34236648 |
10.1007/978-1-0716-1669-7_20 |
2021 |
Generation and Surgical Analysis of Genetic Mouse Models to Study NF-κB-Driven Pathogenesis of Diffuse Large B Cell Lymphoma. |
CARD11 |
| 43 |
34256839 |
10.1186/s40164-021-00232-3 |
2021 |
Progress in molecular feature of smoldering mantle cell lymphoma. |
CARD11 |
| 44 |
34447369 |
10.3389/fimmu.2021.671755 |
2021 |
Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management. |
CARD11 |
| 45 |
34559885 |
10.1111/cei.13662 |
2021 |
Progressive B cell depletion in human MALT1 deficiency. |
CARD11 |
| 46 |
34651869 |
10.1002/hon.2933 |
2021 |
The resistance mechanisms and treatment strategies of BTK inhibitors in B-cell lymphoma. |
CARD11 |
| 47 |
34679437 |
10.3390/diagnostics11101739 |
2021 |
Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis. |
CARD11 |
| 48 |
34722279 |
10.3389/fonc.2021.733848 |
2021 |
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma. |
CARD11 |
| 49 |
34868072 |
10.3389/fimmu.2021.786572 |
2021 |
Clinical and Immunological Features of Human BCL10 Deficiency. |
CARD11 |
| 50 |
31423576 |
10.1111/bjh.16159 |
2020 |
M7-FLIPI is not prognostic in follicular lymphoma patients with first-line rituximab chemo-free therapy. |
CARD11 |
| 51 |
31738823 |
10.1182/blood.2019002699 |
2020 |
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma. |
CARD11 |
| 52 |
31883669 |
10.1016/j.pathol.2019.09.014 |
2020 |
The clinicopathological and genetic features of ovarian diffuse large B-cell lymphoma. |
CARD11 |
| 53 |
31961340 |
10.1172/JCI97040 |
2020 |
GRK2 suppresses lymphomagenesis by inhibiting the MALT1 proto-oncoprotein. |
CARD11 |
| 54 |
31964218 |
10.1177/1078155219895079 |
2020 |
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level. |
CARD11 |
| 55 |
32059783 |
10.1016/j.cell.2020.01.029 |
2020 |
Lymphoma Driver Mutations in the Pathogenic Evolution of an Iconic Human Autoantibody. |
CARD11 |
| 56 |
32473470 |
10.1016/j.cellimm.2020.104129 |
2020 |
Gain-of-function mutations in CARD11 promote enhanced aggregation and idiosyncratic signalosome assembly. |
CARD11 |
| 57 |
32565964 |
10.3892/ol.2020.11552 |
2020 |
Comprehensive characterization of driver genes in diffuse large B cell lymphoma. |
CARD11 |
| 58 |
32574386 |
10.1111/ejh.13467 |
2020 |
MALT-1 as a novel therapeutic target for adult T-cell leukemia. |
CARD11 |
| 59 |
32598477 |
10.1182/bloodadvances.2019001350 |
2020 |
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis. |
CARD11 |
| 60 |
32721634 |
10.1016/j.cellimm.2020.104158 |
2020 |
Critical protein-protein interactions within the CARMA1-BCL10-MALT1 complex: Take-home points for the cell biologist. |
CARD11 |
| 61 |
32770099 |
10.1038/s41598-020-70310-9 |
2020 |
Genetic heterogeneity and prognostic impact of recurrent ANK2 and TP53 mutations in mantle cell lymphoma: a multi-centre cohort study. |
CARD11 |
| 62 |
32771677 |
10.1016/j.cellimm.2020.104189 |
2020 |
The CBM complex: A growing multiplicity of cellular functions, regulatory mechanisms and connections to human disease. |
CARD11 |
| 63 |
32779615 |
10.3960/jslrt.20019 |
2020 |
Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma. |
CARD11 |
| 64 |
33052237 |
10.7150/thno.47533 |
2020 |
Targeting BCL10 by small peptides for the treatment of B cell lymphoma. |
CARD11 |
| 65 |
33154951 |
10.3389/fonc.2020.591577 |
2020 |
Genetic and Non-Genetic Mechanisms of Resistance to BCR Signaling Inhibitors in B Cell Malignancies. |
CARD11 |
| 66 |
33188997 |
10.1016/j.ctarc.2020.100235 |
2020 |
Activity of ibrutinib plus R-CHOP in diffuse large B-cell lymphoma: Response, pharmacodynamic, and biomarker analyses of a phase Ib study. |
CARD11 |
| 67 |
33202260 |
10.1016/j.ajhg.2020.10.015 |
2020 |
Multiplexed Functional Assessment of Genetic Variants in CARD11. |
CARD11 |
| 68 |
33216547 |
10.1021/acs.jmedchem.0c01246 |
2020 |
Optimization of the <i>In Vivo</i> Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood. |
CARD11 |
| 69 |
33329596 |
10.3389/fimmu.2020.601926 |
2020 |
Cellular and Mathematical Analyses of LUBAC Involvement in T Cell Receptor-Mediated NF-κB Activation Pathway. |
CARD11 |
| 70 |
29734251 |
10.1097/PAI.0000000000000585 |
2019 |
MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma. |
CARD11 |
| 71 |
30360939 |
10.1016/j.leukres.2018.10.003 |
2019 |
Immunohistochemical distinction of ABC and GCB in extranodal DLBCL is not reflected in mutation patterns. |
CARD11 |
| 72 |
30508305 |
10.1002/cncr.31831 |
2019 |
Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. |
CARD11 |
| 73 |
30514565 |
10.1016/j.cellimm.2018.11.001 |
2019 |
Ubiquitination and phosphorylation of the CARD11-BCL10-MALT1 signalosome in T cells. |
CARD11 |
| 74 |
30986496 |
10.1016/j.exphem.2019.03.004 |
2019 |
ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia. |
CARD11 |
| 75 |
31000522 |
10.1158/0008-5472.CAN-18-3438 |
2019 |
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma. |
CARD11 |
| 76 |
31060714 |
10.1016/j.jaci.2019.03.009 |
2019 |
Germline CBM-opathies: From immunodeficiency to atopy. |
CARD11 |
| 77 |
31092922 |
10.1038/s41586-019-1215-2 |
2019 |
Targeting the CBM complex causes T<sub>reg</sub> cells to prime tumours for immune checkpoint therapy. |
CARD11 |
| 78 |
31132650 |
10.1016/j.anndiagpath.2019.05.004 |
2019 |
TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant. |
CARD11 |
| 79 |
31138793 |
10.1038/s41467-019-10203-2 |
2019 |
Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells. |
CARD11 |
| 80 |
31150604 |
10.1016/j.jid.2019.05.008 |
2019 |
Mutations of the B-Cell Receptor Pathway Confer Chemoresistance in Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type. |
CARD11 |
| 81 |
31296852 |
10.1038/s41467-019-10953-z |
2019 |
Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation. |
CARD11 |
| 82 |
31391255 |
10.1074/jbc.RA119.009551 |
2019 |
Coordinated regulation of scaffold opening and enzymatic activity during CARD11 signaling. |
CARD11 |
| 83 |
31554683 |
10.1128/JVI.01499-19 |
2019 |
Host CARD11 Inhibits Newcastle Disease Virus Replication by Suppressing Viral Polymerase Activity in Neurons. |
CARD11 |
| 84 |
31644910 |
10.1016/j.celrep.2019.09.040 |
2019 |
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor Cells. |
CARD11 |
| 85 |
31662757 |
10.1155/2019/9832956 |
2019 |
MicroRNA-181a Inhibits Activated B-Cell-Like Diffuse Large B-Cell Lymphoma Progression by Repressing <i>CARD11</i>. |
CARD11 |
| 86 |
29074501 |
10.1182/blood-2017-09-804641 |
2018 |
Single-agent ibrutinib in relapsed or refractory follicular lymphoma: a phase 2 consortium trial. |
CARD11 |
| 87 |
29382759 |
10.1073/pnas.1721967115 |
2018 |
Assembly mechanism of the CARMA1-BCL10-MALT1-TRAF6 signalosome. |
CARD11 |
| 88 |
29587428 |
10.3390/biomedicines6020038 |
2018 |
NF-κB Activation in Lymphoid Malignancies: Genetics, Signaling, and Targeted Therapy. |
CARD11 |
| 89 |
29649481 |
10.1016/j.bbrc.2018.04.057 |
2018 |
Role of IκB kinase β in regulating the remodeling of the CARMA1-Bcl10-MALT1 complex. |
CARD11 |
| 90 |
29891112 |
10.1016/j.critrevonc.2018.05.010 |
2018 |
Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. |
CARD11 |
| 91 |
29899297 |
10.3390/ijms19061758 |
2018 |
Molecular Mechanisms of Disease Progression in Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type during Ibrutinib Therapy. |
CARD11 |
| 92 |
29925955 |
10.1038/s41586-018-0290-0 |
2018 |
A multiprotein supercomplex controlling oncogenic signalling in lymphoma. |
CARD11 |
| 93 |
30022982 |
10.3389/fimmu.2018.01539 |
2018 |
BCL10 - Bridging CARDs to Immune Activation. |
CARD11 |
| 94 |
30032036 |
10.1016/j.neo.2018.07.001 |
2018 |
Mutational Intratumor Heterogeneity is a Complex and Early Event in the Development of Adult T-cell Leukemia/Lymphoma. |
CARD11 |
| 95 |
30087457 |
10.1038/s41374-018-0096-6 |
2018 |
Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues. |
CARD11 |
| 96 |
30127060 |
10.1084/jem.20180230 |
2018 |
Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation. |
CARD11 |
| 97 |
30214442 |
10.3389/fimmu.2018.01927 |
2018 |
Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling. |
CARD11 |
| 98 |
30279415 |
10.1038/s41467-018-06573-8 |
2018 |
Molecular architecture and regulation of BCL10-MALT1 filaments. |
CARD11 |
| 99 |
30283440 |
10.3389/fimmu.2018.02078 |
2018 |
The CBM-opathies-A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex. |
CARD11 |
| 100 |
30283447 |
10.3389/fimmu.2018.02105 |
2018 |
Mechanisms of Regulated and Dysregulated CARD11 Signaling in Adaptive Immunity and Disease. |
CARD11 |
Datasets
Models
